Clinical Trial

Daily Intake of Multivitamin & Mineral Supplementation Effects on Biological Age of Relatively Healthy Middle-aged Individuals

Study acronym: CEDIRA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 30, 2024 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Micronutrients, such as vitamins and minerals, are required to sustain fundamental physiological processes in individuals. As individuals age, the risk of having suboptimal levels of micronutrients increases due to several age-related changes affecting their digestion and assimilation processes. Suboptimal levels of micronutrients have been associated with increased risk of chronic diseases and accelerated ageing. Three years intake of a multivitamin and mineral supplement (MVM) improved global cognition, episodic memory and executive function in older adults. Furthermore, suboptimal micronutrient levels have been associated with a higher biological age, and diet and lifestyle interventions might lower the biological age measured by methylation clocks. Therefore, further evaluation is warranted to determine if MVM supplementation could improve the biological age and clinical outcomes in individuals with a higher biological age.
Trial Details
NCT Number NCT06666660
Lead Sponsor National University of Singapore
Collaborators: HALEON
Conditions Relatively Healthy Volunteers
Enrollment 400 participants
Start Date 2024-09-23
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-30